Drug intelligence / Profile preview

TFE3 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

TFE3 siRNA is a small interfering RNA (siRNA) designed to silence the expression of the Transcription Factor E3 (TFE3). In the context of TSC1-mutant bladder cancer, TFE3 undergoes constitutive nuclear localization and drives a transcriptional program associated with mTORC1 activation and lysosomal biogenesis. Experimental studies demonstrate that siRNA-mediated knockdown of TFE3 significantly reduces cell growth and viability in TSC1-null bladder cancer models, identifying TFE3 as a potential targetable dependency for this molecular subset of tumors. This approach aims to inhibit the aberrant transcriptional activity of TFE3 that contributes to tumor development and maintenance.

Other names
Transcription factor E3 siRNAsiTFE3siTFE-3siTFE 3
02

Targets

Innate immune RNA sensorsAGO2 (Argonaute RISC catalytic component 2)TFE3 (Transcription factor E3)

Beyond the preview

Go deeper on TFE3 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TFE3 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call